You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dolutegravir, rilpivirine drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial (Dolutegravir/Rilpivirine FDC)

Not yet recruiting
  • HIV Infections
  • Dolutegravir/Rilpivirine FDC
  • (no location specified)
Jan 5, 2023

HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)

Completed
  • HIV-1-infection
  • Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
  • San Francisco, California
    SFOMG Private Practice
Jan 27, 2022

Study Using Real-world Data in Human Immunodeficiency Virus-1

Recruiting
  • HIV Infections
  • Tuebingen, Baden-Wuerttemberg, Germany
  • +22 more
Jan 12, 2023

Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Nov 2, 2022

HIV/AIDS, ESRD Trial in Indianapolis (JULUCA 50Mg-25Mg Tablet)

Recruiting
  • HIV/AIDS
  • ESRD
  • JULUCA 50Mg-25Mg Tablet
  • Indianapolis, Indiana
    Samir Gupta
Dec 1, 2021

HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

Active, not recruiting
  • HIV-1-infection
  • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
  • Antwerp, Belgium
  • +28 more
May 23, 2022

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022

HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

Recruiting
  • HIV-1-infection
  • Kisumu, Kenya
  • +6 more
Feb 1, 2023

HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

Not yet recruiting
  • HIV Infections
  • (no location specified)
Jun 13, 2023

Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)

Completed
Has Results
  • Tuberculosis
  • HIV Infections
  • Lima, Peru
  • +2 more
Jan 20, 2022

HIV-1-infection, Antiviral Drug Adverse Reaction, Vascular Diseases Trial in Augusta (Dolutegravir 50 MG, Antiretroviral/Anti

Unknown status
  • HIV-1-infection
  • +7 more
  • Dolutegravir 50 MG
  • Antiretroviral/Anti HIV
  • Augusta, Georgia
    Augusta University
Jan 11, 2021

Effect on HIV Medications on EPC Cells

Completed
  • AIDS
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil

Recruiting
  • HIV Infections
  • Fatty Liver Disease
  • Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
  • +2 more
  • Madrid, Spain
  • +3 more
Jun 13, 2023

HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

Not yet recruiting
  • HIV Infection
  • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
  • (no location specified)
Aug 8, 2023

Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

Recruiting
  • Human Immunodeficiency Virus Type 1
  • Brescia, Italy
  • +13 more
Jan 17, 2023

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

Not yet recruiting
  • HIV-1-infection
  • (no location specified)
Aug 12, 2022

HIV Trial in Worldwide (Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate

Recruiting
  • HIV Infections
  • Dolutegravir film-coated tablets
  • +3 more
  • Los Angeles, California
  • +16 more
Sep 29, 2022

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy

Active, not recruiting
  • HIV Infections
  • Cultural Domain Analysis
  • +2 more
  • Brighton, United Kingdom
    Royal Sussex County Hospital, Brighton, UK
May 18, 2022

HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

Active, not recruiting
  • HIV-1-infection
  • Butha-Buthe, Lesotho
  • +1 more
Oct 23, 2022

Infection, Human Immunodeficiency Virus, HIV Trial in Overland Park (DTG, RPV, DTG/RPV FDC)

Completed
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Overland Park, Kansas
    GSK Investigational Site
Jul 11, 2019

HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

Active, not recruiting
  • HIV-1/HBV Co-Infection
  • Fort Pierce, Florida
  • +66 more
Sep 19, 2022

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

Human Immunodeficiency Virus Infections Trial in India (Rilpivirine 25 mg, Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC))

Terminated
  • Human Immunodeficiency Virus Infections
  • Rilpivirine 25 mg
  • Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)
  • Bengaluru, India
  • +5 more
Jun 23, 2022